Will Insurance or a Government Scheme — Pay for Osimertinib?

Being listed in the PMJAY framework means it can be covered, not that it automatically will be. Your hospital must be empanelled, your family must be a verified beneficiary, and the hospital's PMJAY cell must process the claim under the correct oncology package. If any of those conditions is not in place, the drug is not covered through that route even if it appears in the national list. Ask the hospital's PMJAY or insurance desk before your first cycle, not after you have already purchased.

Older policies were written before oral targeted therapies became standard and often treat them differently from intravenous chemotherapy given in hospital. Some policies specifically exclude 'drugs administered outside hospital', which captures oral targeted therapies even though you take them at home on prescription. Read your policy document under 'exclusions' and 'cancer treatment', then call the insurer and ask directly: is osimertinib covered, and is prior authorisation required. Note the date and the name of the person you spoke to.

AstraZeneca operates patient access schemes for Tagrisso in India for patients who cannot afford treatment at full cost. The programme is income-based and requires documentation of financial status alongside an oncologist's recommendation. Application is made through the treating oncologist or hospital pharmacy team rather than directly by the patient. Criteria and availability can change, so your oncology team is the right starting point — they will have the most current information about how the programme is operating.

Telangana has run cancer drug assistance through the Aarogyasri programme and government hospital dispensing channels. The specific drugs covered and the application process are updated by the state government periodically, which means information found online goes out of date quickly. Your most reliable source of current details is the social work or patient support desk at your treating government hospital in Telangana — they deal with these applications regularly and will know what is available right now.

Pre-authorisation means your insurer needs to approve coverage before you start the drug. If you buy first and then claim, they may deny the claim because they were not given the opportunity to verify before the expense was incurred. The process usually involves your oncologist submitting the prescription, the EGFR mutation test result and a clinical justification to the insurer. Allow at least a week, and ask your oncology team to support the documentation — experienced teams have been through this process many times.

Tell your oncologist directly that cost is a constraint. Oncologists working in hospitals with a social work team can sometimes access compassionate supply routes or connect you with NGOs that assist with drug costs for cancer patients in India. In some situations, clinical trials open for EGFR-mutant lung cancer may provide the drug at no cost, though eligibility for trials has its own criteria. Being honest about cost as a barrier opens options that a family who says nothing will not hear about.